The Biology of Cannabis: Understanding What's on Your Dispensary Menu

The Molecular Architecture: CB1 and CB2 Receptors

Cannabinoids influence physiology by docking onto specific G protein-coupled receptors. The location of these receptors in the body determines the effect experienced after consumption.

CB1 Receptors: Central Nervous System Modulation

CB1 receptors are found throughout the brain and central nervous system. They are densely packed in the hippocampus (involved in memory), the basal ganglia (which controls motor function), and the cerebral cortex (the center for executive thought).

• THC Interaction: Delta-9-Tetrahydrocannabinol (THC) acts as a partial agonist to the CB1 receptor. It locks into place, triggering a dopamine release while shifting neurotransmitter signaling.
• The Outcome: This interaction may be associated with psychoactive effects, alterations in time perception, and the stimulation of appetite.

CB2 Receptors: Immune and Peripheral Regulation

CB2 receptors operate differently. They are primarily stationed in the peripheral nervous system, specifically within immune cells, the spleen, and the gastrointestinal tract.

• CBD and Terpene Interaction: Unlike THC, CBD does not bind neatly to these receptors. Instead, it acts as an allosteric modulator, subtly changing the receptor's shape to influence how other signals are received.
• The Outcome: Activation here may support the calming of systemic inflammation and the modulation of immune responses, without the psychoactive effects linked to CB1 engagement.

Metabolic Pathways: Inhalation vs. Ingestion

The method of consumption alters the chemical structure of THC before it reaches the brain.

Pulmonary Absorption (Inhalation)

Inhaling smoke or vapor allows THC to pass through the alveolar sacs in the lungs and enter the bloodstream immediately. Because it bypasses the digestive tract and the liver, it reaches the brain within seconds as Delta-9-THC.

First-Pass Metabolism (Edibles)

Eating cannabis requires the liver to process the compound before it reaches the bloodstream. This is a transformation known as first-pass metabolism:

1. The liver enzyme CYP2C9 breaks down the Delta-9-THC.
2. It reassembles the molecule into 11-Hydroxy-THC.
3. 11-Hydroxy-THC is more potent and crosses the blood-brain barrier with greater ease.

This metabolic process explains why edibles may feel more intense and last longer than inhaled cannabis, even if the starting milligram dose is identical.

Terpenes as Bioactive Chemical Modulators

Terpenes are functional lipids that act as traffic controllers for cannabinoids. This synergy is known as the Entourage Effect.

• Myrcene: This monoterpene may increase the permeability of the blood-brain barrier. By making that barrier more porous, it may allow THC to reach CB1 receptors more efficiently, which is a potential reason why high-myrcene profiles are often associated with sedative effects.
• Alpha-Pinene: Pinene acts as an acetylcholinesterase inhibitor. By preventing the breakdown of acetylcholine—a neurotransmitter involved in memory—it may help offset short-term memory impairment often linked to THC.
• Beta-Caryophyllene: This is a unique terpene that functions like a cannabinoid. It binds to the CB2 receptor, offering support for inflammation that may work independently of THC or CBD.

Enzymatic Degradation and Genetic Variance

Individual responses to cannabis vary significantly, often due to the FAAH (Fatty Acid Amide Hydrolase) enzyme. FAAH is responsible for breaking down anandamide, the body’s endogenous equivalent of THC.

Genetic Baseline

Some individuals have a genetic predisposition for lower FAAH production. These individuals naturally carry higher levels of anandamide, which can manifest as higher baseline anxiety. When they consume THC, their system may become easily overwhelmed, sometimes leading to acute paranoia.

Receptor Downregulation

The body maintains balance through adaptation. If high doses of THC are introduced frequently, the brain may respond by "silencing" or retracting its CB1 receptors to prevent overstimulation. This is downregulation. If a typical dose becomes less effective, it may be that receptors have been turned down; a "tolerance break" allows them to reset to their original density.

Strategic Selection Criteria

Rather than relying on vague strain names, focus on the chemical ratios to predict potential experiences:

1. The 1:1 Rule: A 1:1 CBD to THC ratio may be helpful for balance. The CBD modulates the CB1 receptor to keep the experience grounded while maximizing the immune-supporting potential of the CB2 receptors.
2. Terpene Prioritization: If deep relaxation is the goal, look for high Myrcene for its potential sedative properties. If focus is required, prioritize Pinene.
3. Metabolic Timing: Use edibles (11-Hydroxy-THC) for sustained support. Reserve inhalation (Delta-9-THC) for moments requiring immediate management of symptoms.

---

Legal Disclaimer: This content is for educational and informational purposes only and does not constitute medical advice. Always seek the advice of a physician regarding a medical condition. Efficacy has not been confirmed by FDA-approved research. Check your local laws regarding cannabis and terpene use.

Sources

1. Devane WA, Hanus L, Breuer A, et al. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258(5090):1946-9. PubMed

2. Mechoulam R, Parker LA. (2013). The endocannabinoid system and the brain. Annu Rev Psychol. 64:21-47. PubMed

3. Russo EB. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 163(7):1344-64. PubMed

4. Pertwee RG. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol. 153(2):199-215. PubMed

5. Huestis MA. (2007). Human cannabinoid pharmacokinetics. Chem Biodivers. 4(8):1770-804. PubMed